Biosimulation Technology Market to Cross US$ 2700 Million Globally by 2022

Page 1

Biosimulation Technology Market to Cross US$ 2700 Million Globally by 2022

New York, March 24, 2018: Market Research Engine has published a new report titled as “Biosimulation Technology Market By Application Analysis (Drug Discovery, Drug Development) and By Regional Analysis – Global Forecast by 2016 – 2022”. The Global Biosimulation Technology Market is expected to exceed more than US$ 2700 million by 2022 and will grow at a CAGR of more than 15% in the given forecast period. Browse Full Report: https://www.marketresearchengine.com/reportdetails/biosimulationtechnology-market The major driving factors of Global Biosimulation Technology Market are as follows: • • •

High healthcare expenditure Enhanced simulation technology Advanced software programs

The restraining factors of global Biosimulation Technology market are as follows: • •

Lack of standard method for biosimulation High risk of failure of drugs in biosimulation

The Global Biosimulation Technology Market is segmented on the lines of its application and regional. Application segmentation is further classified into drug discovery and drug development. Drug discovery is classified into lead identification, target identification, lead optimization and target validation. Under drug development segmentation it covers in patient validation and preclinical testing and clinical trials. The Global Biosimulation technology market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: 1) An overview of the global market for Global Biosimulation Technology Market and related technologies. 2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. 3) Identifications of new market opportunities and targeted promotional plans for Global Biosimulation Technology Market. 4) Discussion of research and development, and the demand for new products and new applications.


5) Comprehensive company profiles of major players in the industry. REPORT SCOPE: The scope of the report includes a detailed study of global and regional markets for Global Biosimulation Technology Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Accelrysinc., Schrodinger, ACD/Labs, LeadScope, Certara, Rhenovia, Archimedes, Genedata and Insilico BioTechnology. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Global Biosimulation Technology Market has been segmented as below: By Application Analysis • o o o o • o o

Drug Discovery Lead Identification Target Identification Lead Optimization Target Validation Drug Development In Patient Validation Preclinical Testing and Clinical Trials

By Regional Analysis • • • •

North America Europe Asia-Pacific Rest of the World

Request A Sample Report: https://www.marketresearchengine.com/requestsample/biosimulation-technology-market

Table of Contents 1 INTRODUCTION 2 Research Methodology 3 Executive Summary 4 Premium Insights


5 Market Overview 6 Biosimulation Market, By Product 7 Biosimulation Market, By Application 8 Biosimulation Market, By End User 9 Global Biosimulation Market, By Region 10 Competitive Landscape 11 Company Profiles 11.1 Introduction 11.2 Certara USA, Inc. 11.3 Simulation Plus Inc. 11.4 Dassault Systèmes SA 11.5 Schrödinger Inc. 11.6 Advanced Chemistry Development, Inc. 11.7 Chemical Computing Group, Inc. 11.8 Entelos Holding Corporation 11.9 Genedata Ag 11.10 Physiomics PLC 11.11 Rhenovia Pharma Ltd.

Reasons to Buy this Report: 1) Obtain the most up to date information available on all Global Biosimulation Technology Market. 2) Identify growth segments and opportunities in the industry. 3) Facilitate decision making on the basis of strong historic and forecast of Global Biosimulation Technology Market data. 4) Assess your competitor’s refining portfolio and its evolution.


About MarketResearchEngine Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies. Media Contact Contact Person: John Bay Email: john@marketresearchengine.com Phone: +1-855-984-1862 Country: United States Website: https://www.marketresearchengine.com Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.